Recruiting NCT04755764

Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy

Trial Parameters

Condition Systolic Hypertension

Sponsor Marshall University

Study Type OBSERVATIONAL

Phase N/A

Enrollment 60

Sex FEMALE

Min Age 18 Years

Max Age 45 Years

Start Date 2021-03-03

Completion 2025-12

All Conditions

Systolic Hypertension Pregnancy Related Diastolic Hypertension Cardiac Output, Low Cardiac Output, High

Interventions

LabetalolAtenololNifedipine

Brief Summary

The purpose of the research is to characterize the effect of labetalol, atenolol, and nifedipine on maternal hemodynamics early in pregnancy. Patients will be given medication based on their hemodynamics and asked to return for a repeat measurement.

Eligibility Criteria

Inclusion Criteria: * Patients presenting to Maternal Hypertension Center at Cabell Huntington Hospital * English speaking * 18-45 years old. * Willing to provide informed consent * Gestational age prior to 15 weeks gestation Exclusion Criteria: * Non-English speaking patients, patients * \<18 years old or \>45 years old * Not willing or able to provide consent * Gestational age \>15 weeks

Related Trials

NCT04755764

Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Preg

View Trial →

VIEW ON CLINICALTRIALS.GOV ↗ MORE SYSTOLIC HYPERTENSION TRIALS